The innovative response to COVID-19 spurred the fastest pace of vaccine and drug development ever witnessed, resulting in approved vaccines and therapeutics in under 12 months. These advances, in reality, were many years in the making, fueled by mRNA and monoclonal antibodies research. Can we leverage the lessons learned from COVID-19 to pursue the greatest challenges of medical science: Alzheimer's, cancer, diabetes, future pandemics, rare diseases and more? Come learn about how lessons learned are being pushed forward, as well as a new non-profit model - Focused Research Organizations - that hold the potential to break through scientific bottlenecks to address such areas as brain mapping and synthetic biology.